Press Release regarding the receipt of Establishment Inspection Report (EIR) for the API Unit of the Company located in Chennai from U.S. Food and Drugs Administration (FDA)

pdf

Natco Pharma Ltd.

12 Feb 2026, 08:57PM

823.85

-1.91%

NATCO Pharma Q3 PAT up

Business Line

For the nine-month period, the company posted a net profit of Rs 1,149.50 crore (Rs 1,477.40 crore) on a revenue of Rs 3,339 crore (Rs 3,208.50 crore).

Natco Pharma has lost -32.40% in the last 1 Year

Natco Pharma Ltd.

12 Feb 2026, 04:00PM

823.85

-1.91%

Corp. Action

Natco Pharma Ltd - 524816 - Corporate Action-Board approves Dividend

BSE India

Board of Directors at their meeting held today declared 3rd Interim Dividend of Rs.1.50 per equity share of Rs.2/- each

pdf

Natco Pharma Ltd.

12 Feb 2026, 03:58PM

823.85

-1.91%

Company Update

Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Meeting Updates

BSE India

The Board of Directors at their meeting held today approved to incorporate a wholly owned subsidiary in CHILE

pdf

Natco Pharma Ltd.

12 Feb 2026, 03:54PM

823.85

-1.91%

Company Update

Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

1. Superannuation of Mr. S V V N Appa Rao, Chief Financial Officer w.e.f. closure of business hours on 12th February, 2026 2. Appointment of Mr. Amit Parekh as Chief Financial Officer of the Company w.e.f. 13th February, 2026. 3. Appointment of Mr. K Srinivasa Rao as Executive Vice President- Pharma Division w.e.f. 12th February, 2026

pdf

Natco Pharma Ltd.

12 Feb 2026, 03:04PM

823.85

-1.91%

Investor Presentation

Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Q3 earning for FY 2025-26

pdf

Natco Pharma Ltd.

12 Feb 2026, 03:04PM

823.85

-1.91%

to see Rapid results content

Natco Pharma Ltd.

12 Feb 2026, 02:49PM

823.85

-1.91%

Result

Natco Pharma Ltd - 524816 - Un Audited Financial Results For The Quarter Ending 31St December, …

BSE India

Un audited Financial Results for the quarter ending 31st December, 2025

pdf

	Dec 2025	Sep 2025	Dec 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	705.40	1463.00	651.10	-51.8%	8.3%
Operating Profit Qtr	158.70	579.20	38.80	-72.6%	309.0%
Net Profit Qtr	151.50	518.40	133.00	-70.8%	13.9%
Earning Per Share Adjusted latest Qtr	8.46	28.94	7.43	-70.8%	13.9%